MARC details
000 -LEADER |
fixed length control field |
03029nam a22004097a 4500 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
210218s20212021 xxu||||| |||| 00| 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER |
International Standard Serial Number |
2000-9666 |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1080/20009666.2020.1836726 [doi] |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
1836726 [pii] |
024 ## - OTHER STANDARD IDENTIFIER |
Standard number or code |
PMC7850392 [pmc] |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
Ovid MEDLINE(R) |
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC) |
PMID |
33552425 |
245 ## - TITLE STATEMENT |
Title |
Acquired Hemophilia A and urothelial carcinoma. |
251 ## - Source |
Source |
Journal of Community Hospital Internal Medicine Perspectives. 11(1):89-93, 2021 Jan 26. |
252 ## - Abbreviated Source |
Abbreviated source |
J Community Hosp Intern Med Perspect. 11(1):89-93, 2021 Jan 26. |
253 ## - Journal Name |
Journal name |
Journal of community hospital internal medicine perspectives |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Year |
2021 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Manufacturer |
FY2021 |
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE] |
Publication status |
epublish |
266 ## - Date added to catalog |
Date added to catalog |
2021-02-18 |
520 ## - SUMMARY, ETC. |
Abstract |
Acquired Hemophilia A (AHA) is a rare entity, resulting from the production of autoantibodies against Factor VIII of the coagulation cascade. These autoantibodies may develop in response to autoimmune conditions, drugs, neoplastic diseases, and pregnancy. Diagnosis involves clinical presentation, mucocutaneous or intramuscular bleeding, and laboratory findings, such as prolonged activated partial thromboplastin time, decreased levels of Factor VIII, and the presence of Factor VIII autoantibodies. The etiology is diverse, with a variety of underlying culprits. Malignancy-associated AHA has been associated with approximately 15% of cases. Urothelial malignancy-mediated AHA is exceedingly rare, with only two previously published reports. The management of AHA includes stabilization and control of bleeding via the use of hemostatic agents, and elimination of the inhibitor with immunosuppressive therapy. Here, we report a case of AHA secondary to urothelial malignancy and review the pathobiology and pathogenesis of Hemophilia A and AHA. Copyright (c) 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center. |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
IN PROCESS -- NOT YET INDEXED |
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Institution |
MedStar Medical Group |
656 ## - INDEX TERM--OCCUPATION |
Department |
Internal Medicine |
656 ## - INDEX TERM--OCCUPATION |
Department |
MedStar Health Baltimore Residents |
657 ## - INDEX TERM--FUNCTION |
Medline publication type |
Case Reports |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Haas, Christopher |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Paz, Robert |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Suleman, Nawar |
700 ## - ADDED ENTRY--PERSONAL NAME |
Local Authors |
Taza, Fadi |
790 ## - Authors |
All authors |
Haas C, Paz R, Suleman N, Taza F |
856 ## - ELECTRONIC LOCATION AND ACCESS |
DOI |
<a href="https://dx.doi.org/10.1080/20009666.2020.1836726">https://dx.doi.org/10.1080/20009666.2020.1836726</a> |
Public note |
https://dx.doi.org/10.1080/20009666.2020.1836726 |
858 ## - ORCID |
ORCID text |
Suleman, Nawar |
-- |
Taza, Fadi |
Orcid |
<a href="https://orcid.org/0000-0001-6537-7472">https://orcid.org/0000-0001-6537-7472</a> |
-- |
<a href="https://orcid.org/0000-0002-6478-8170">https://orcid.org/0000-0002-6478-8170</a> |
Name |
https://orcid.org/0000-0001-6537-7472 |
-- |
https://orcid.org/0000-0002-6478-8170 |
-- |
https://orcid.org/0000-0001-6537-7472 |
-- |
https://orcid.org/0000-0002-6478-8170 |
858 ## - ORCID |
ORCID text |
Suleman, Nawar |
-- |
Taza, Fadi |
Orcid |
<a href="https://orcid.org/0000-0001-6537-7472">https://orcid.org/0000-0001-6537-7472</a> |
-- |
<a href="https://orcid.org/0000-0002-6478-8170">https://orcid.org/0000-0002-6478-8170</a> |
Name |
https://orcid.org/0000-0001-6537-7472 |
-- |
https://orcid.org/0000-0002-6478-8170 |
-- |
https://orcid.org/0000-0001-6537-7472 |
-- |
https://orcid.org/0000-0002-6478-8170 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Koha item type |
Journal Article |
Item type description |
Article |